UiPath, Inc. (PATH) › Analysis

UiPath, Inc. (PATH) stock analysis, February 17, 2026: PATH tests $11.05 after erasing the WorkFusion rally, with earnings due March 11

Published February 17, 2026 · PATH chart, levels and live analysis

Executive Summary

UiPath shares declined 5.43% to $11.05 since the February 12 report, marking a new 52-week low and extending YTD losses to -32.55%. The stock has now erased 14.96% over five trading sessions, signaling persistent selling pressure ahead of the Q4 FY2026 earnings release scheduled for March 11, 2026. While competitive dynamics in the automation space remain intense with adjacent players strengthening their positions, the RPA market continues to exhibit robust structural growth potential with a projected 28.47% CAGR through 2032.

Key Updates

UiPath shares fell 5.43% to $11.05 since the February 12 report, establishing a fresh multi-month low and accelerating the post-acquisition correction. The stock has declined 14.96% over the past five trading sessions, completely reversing the 11.13% WorkFusion acquisition rally documented in early February reports. YTD performance has deteriorated to -32.55%, while the one-month decline of -22.91% represents the most severe compression in recent quarters. The 6-month performance of +0.87% indicates the stock remains range-bound with no sustained directional momentum. Trading volume and volatility patterns suggest institutional positioning ahead of the March 11 earnings release, with the current price representing a critical technical juncture near previous support levels.

Current Trend

UiPath is experiencing severe downward pressure with the YTD decline of -32.55% representing substantial wealth destruction for shareholders. The stock has broken below the $11.69 support level identified in the February 12 report and now trades at $11.05, establishing a new low-water mark. The five-day decline of -14.96% indicates accelerating selling momentum rather than stabilization, while the one-month drop of -22.91% suggests systematic de-risking by institutional holders. The 6-month performance of +0.87% provides minimal comfort, as the entire gain has been compressed into a narrow range between $11-13. Technical indicators point to continued weakness with no clear support level until the psychological $10 threshold. The stock is trading significantly below all major moving averages, with deteriorating relative strength suggesting underperformance versus both technology sector peers and broader market indices.

Investment Thesis

The investment thesis centers on UiPath's positioning as a leader in the rapidly expanding agentic automation market, combining AI agents with robotic process automation to address the $20.79 billion opportunity projected by 2032. The RPA market is growing at 28.47% CAGR, driven by enterprises achieving 25-35% operational cost reductions and 20-30% faster process cycle times through platform-centric automation solutions. The WorkFusion acquisition strengthens UiPath's vertical expertise in financial services, addressing high-value use cases in AML, KYC, sanctions screening, and transaction monitoring where regulatory complexity creates defensible moats. However, the thesis faces headwinds from intensifying competition as platform-centric vendors command 30-40% higher enterprise deal values, attracting capital and innovation from Microsoft, IBM, and specialized players. The upcoming Q4 FY2026 earnings on March 11 will be critical for validating execution against the agentic automation vision and demonstrating WorkFusion integration progress.

Thesis Status

The investment thesis remains structurally intact but faces near-term execution risk as reflected in the -32.55% YTD decline. The market appears to be discounting concerns about UiPath's ability to capture its fair share of the expanding RPA/automation opportunity amid competitive pressure from Microsoft, IBM, and other platform vendors. The WorkFusion acquisition validates the strategic direction toward vertical-specific agentic solutions, particularly in financial services where compliance automation commands premium pricing. However, the persistent selling pressure since the acquisition announcement suggests investors remain skeptical about integration execution, revenue synergies, or the deal's financial terms. Competitive dynamics have intensified as evidenced by adjacent players like Unchained Labs launching AI-driven automation platforms and Microsoft ecosystem partners like TeamDynamix expanding their marketplace presence. The March 11 earnings release will be pivotal for reassessing whether management can articulate a compelling path to market share gains and margin expansion that justifies the current valuation, or whether further multiple compression is warranted.

Key Drivers

The primary near-term catalyst is the Q4 FY2026 earnings release scheduled for March 11, 2026, which will provide visibility into full-year fiscal 2026 performance and initial guidance for fiscal 2027. Management commentary on the WorkFusion integration, financial services pipeline development, and agentic automation adoption rates will be critical for investor sentiment. The broader RPA market backdrop remains constructive, with the industry projected to grow from $3.60 billion in 2025 to $20.79 billion by 2032, representing substantial TAM expansion. However, competitive pressure is intensifying as platform-centric vendors consolidate market share, with UiPath competing against Microsoft, IBM, Automation Anywhere, Blue Prism, and Pegasystems for enterprise deals. The strong performance of adjacent AI platforms like Palantir, which reported 60% revenue growth guidance and achieved a 127% Rule of 40 score, highlights the market's appetite for AI-driven enterprise solutions but also raises the competitive bar for execution. Sector-wide dynamics including enterprise AI spending patterns, macroeconomic conditions affecting IT budgets, and the pace of agentic automation adoption will influence UiPath's ability to capture growth opportunities.

Technical Analysis

UiPath is in a confirmed downtrend with the current price of $11.05 representing a new multi-month low and a -32.55% YTD decline. The stock has broken through the $11.69 support level identified in the February 12 report and the $12.89 level from the February 6 analysis, indicating systematic erosion of technical support. The five-day decline of -14.96% demonstrates accelerating downward momentum with no signs of stabilization, while the one-month drop of -22.91% suggests sustained institutional selling pressure. Volume patterns likely indicate distribution rather than capitulation, with the stock trading below all major moving averages. The 6-month performance of +0.87% shows the stock remains trapped in a wide trading range between approximately $11-14, with the current price testing the lower boundary. Key resistance now exists at $11.69, $12.89, and $13.29 (previous support levels that have been violated). The next meaningful support level sits at the psychological $10 threshold, representing an additional 9.5% downside risk. Relative strength indicators suggest continued underperformance versus technology sector benchmarks, with deteriorating momentum metrics pointing to further near-term weakness absent a positive catalyst from the March 11 earnings release.

Bull Case

Bear Case

Get a message when the PATH picture changes — the agent team watches the levels and the news for you.Create a free account

More PATH analyses